LB Pharmaceuticals Inc
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-34.5M | — |
| FY2024 | — | $-94.6M | $23.0M |
| FY2025 | — | $301.3M | $250.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-34.5M | — |
| FY2024 | — | $-94.6M | $23.0M |
| FY2025 | — | $301.3M | $250.2M |